Dr Leanne Rees awarded Travelling Fellowship

Dr Leanne Rees has been awarded the QUT  Alan Mackay‐Sim Spinal Cord Injury Travelling Fellowship, which aims to improve clinical outcomes and quality of life for people with a spinal cord injury.

Dr Rees is a research officer in the PREPARE theme of the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, and in the Murdoch Children’s Research Institute’s Stem Cell Ethics & Policy group. She is also a senior physiotherapist in spinal cord injury rehabilitation at Austin Health, and recently completed her PhD at La Trobe University investigating the representation, creation and impact of spinal cord injury in Australian news media. Dr Rees is now investigating how healthcare professionals navigate conversations of hope considering media portrayals of stem cell therapies at reNEW Melbourne.

The aim of this travel fellowship is to gain an in-depth understanding of how spinal cord injury is communicated in an international context and identify strategies to address media informed attitudes and beliefs towards spinal cord injury. Findings will also have relevance to challenges experienced by patients and their families when making healthcare decisions following the diagnosis of other acquired or chronic conditions, in a time where information is readily sourced through the Internet and mass media.

“This new knowledge will help inform practices to help improve experiences and rehabilitation outcomes for people with spinal cord injury here in Australia and help frame my research at reNEW and Murdoch Children’s. I’m excited and thankful for QUT for giving me this opportunity,” Dr Rees said.

Esteemed colleagues from reNEW elected members of EMBO

The Novo Nordisk Foundation Center for Stem Cell Medicine is proud to announce that CEO and Executive Director of reNEW, Professor Mellissa H. Little and Principal Investigator at reNEW’s Copenhagen node, Professor Joshua Brickman, have this year been elected members of the prestigious European Molecular Biology Organization – EMBO.

4M euros for research into nuclear metabolism

Associate Professor Jan Żylicz from reNEW Copenhagen node, as part of an international consortium, has been awarded an MSCA Doctoral Networks Grant for project; NUCLEAR – metabolic regulation of genome function and cell identity.

The Serup Group in Copenhagen break new ground on the development of a stem cell therapy to treat diabetes

Assistant Professor Philip Seymour, former Assistant Professor Nina Funa and PhD student Heidi Mjøseng, with colleagues from the Serup Group at the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, University of Copenhagen, have had a paper published in Stem Cell Reports investigating further development of a cellular therapy to replace the lost insulin-producing beta cells in type one diabetics.